Self-sampling to Optimize Anal Lesion Outcomes — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Self-sampling to Optimize Anal Lesion Outcomes — Stella

Home/Anal Cancer/

View on ClinicalTrials.gov

Recruiting

Back to Anal Cancer trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(3 sites)

United States

University of Chicago, Chicago, Illinois

The University of Texas M.D. Anderson Cancer Center, Houston, Texas

Medical College of Wisconsin, Milwaukee, Wisconsin

Key details

Sponsor

Medical College of Wisconsin

Collaborators

National Cancer Institute (NCI), University of Chicago

Enrollment target

~572 participants

Started

November 2025

Primary completion

March 2028

Age range

35 Years and older

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.